[1] |
Weng J, Pozzilli P. Diabetes Metabolism: Research and Reviews-Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China[J]. Diabetes Metab Res Rev, 2014, 30(6): 445-446. DOI: 10.1002/dmrr.2579.
|
[2] |
American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2011, 34 Suppl 1(Suppl 1): S62-S69. DOI: 10.2337/dc11-S062.
|
[3] |
Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies[J]. Cardiovasc Diabetol, 2018, 17(1): 121. DOI: 10.1186/s12933-018-0763-3.
|
[4] |
Zheng J, Chen S, Albiero ML, et al. Diabetes activates periodontal ligament fibroblasts via NF-κB in vivo[J]. J Dent Res, 2018, 97(5): 580-588. DOI: 10.1177/0022034518755697.
|
[5] |
Dang X, He B, Ning Q, et al. Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways[J]. Respir Res, 2020, 21(1): 95. DOI: 10.1186/s12931-020-01358-4.
|
[6] |
Jiang Z, Shen J, Ding J, et al. USP18 mitigates lipopolysaccharide-induced oxidative stress and inflammation in human pulmonary microvascular endothelial cells through the TLR4/NF-κB/ROS signaling[J]. Toxicol In Vitro, 2021, 75(undefined): 105181. DOI: 10.1016/j.tiv.2021.105181.
|
[7] |
徐秋玲, 郑学芝, 郭冉, 等. 黄芩苷抑制核因子κB信号通路对糖尿病鼠心肌保护机制研究[J]. 现代医药卫生, 2021, 37(13): 2192-2195, 2200. DOI: 10.3969/j.issn.1009-5519.2021.13.009.
|
[8] |
郑小鹏, 冯静, 宋朝宇, 等. 黄芩苷对糖尿病肾病大鼠肾纤维化的调控作用 [J]. 医学研究生学报, 2020, 33(5): 471-475. DOI: 10.16571/j.cnki.1008-8199.2020.05.005.
|
[9] |
梁健欣. 黄芩苷保护胚胎心血管发育的机制研究[D]. 广州: 暨南大学, 2018.
|
[10] |
周礼, 陆正齐, 叶小鸣, 等. 黄芩苷元对糖尿病合并脑小血管病认知障碍的影响[J]. 康复学报, 2018, 28(1): 24-30. DOI: 10.3724/SP.J.1329.2018.01024.
|
[11] |
El-Bassossy HM, Hassan NA, Mahmoud MF, et al. Baicalein protects against hypertension associated with diabetes: effect on vascular reactivity and stiffness[J]. Phytomedicine, 2014, 21(12): 1742-1745. DOI: 10.1016/j.phymed.2014.08.012.
|
[12] |
Leng B, Zhang Y, Liu X, et al. Astragaloside IV suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4/NF-κB and CaSR[J]. Mediators Inflamm, 2019(undefined), 1082497. DOI: 10.1155/2019/1082497.
|
[13] |
Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling[J]. Cell Res, 2011, 21(1): 103-115. DOI: 10.1038/cr.2010.178.
|